NEW YORK (GenomeWeb News) - Cellumen said today that it will collaborate with the Mayo Foundation for Medical Education and Research to apply the company’s cellular systems biology approach to breast cancer patient stratification.
 
Cellumen said that the goal of the project is to create a breast cancer patient profile test to help improve disease treatment and diagnosis.
 
"We are treating breast tumors as a 'system' within the breast cancer patient," said Cellumen's CEO, Lansing Taylor.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.